• LEARN MORE ABOUT KEYNOTE 695
  • About
    • About
    • Join The Team
    • Management Team
  • Pipeline
  • Technology
    • Technology
    • Tavo
    • VLA
    • Combination Approach
    • Publications
  • Partnering
  • Patients
    • Patients
    • Resources
    • Expanded Access
    • Together Against Cancer
  • Investors
  • Media
  • Contact
OncoSec Medical Incorporated
  • About
    • About
    • Join The Team
    • Management Team
  • Pipeline
  • Technology
    • Technology
    • Tavo
    • VLA
    • Combination Approach
    • Publications
  • Partnering
  • Patients
    • Patients
    • Resources
    • Expanded Access
    • Together Against Cancer
  • Investors
  • Media
  • Contact

Governance Documents

Investors

Investors

  • Overview
    • Profile
    • Contacts
  • Events & Presentations
  • Analysts
  • Press Releases
    • Email Alerts
  • Financial Info
  • Stock Info
    • Quote
    • Charts
    • Historical Data
  • Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • FAQ
  • Governance

  • Board of Directors
  • Board Committees
  • Governance Documents

Corporate Governance Guidelines

Download Corporate Governance Guidelines

Code of Business Conduct and Ethics

Download Code of Business Conduct and Ethics

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating & Corporate Governance Committee Charter

Download Nominating & Corporate Governance Committee Charter

Form 8937

Download Form 8937
  • Email Alerts
  • Contacts
  • RSS News Feed
logo

Sign Up for our mailing list to stay current on all of our exciting new research and developments.

Get Email Alerts
OncoSec’s investigational products have not been approved or cleared by the FDA.

Links

  • About
  • Pipeline
  • Technology
  • Partnering
  • Patients
  • Media
  • Investors
  • Contact
  • KEYNOTE 695 CLINICAL TRIAL

Contact

New Jersey Headquarters
820 Bear Tavern Road
Suite 200
Ewing, NJ 08628

R&D Laboratories
3565 General Atomics Court #100
San Diego, CA 92121

p | 855.662.6732
f | 858.430.3832

Investors@OncoSec.com


© 2023 OncoSec Medical Incorporated. All Rights Reserved. Q12-003052-01 REV E.